Clinical Trials Browser

Phase 2 × Mesothelioma × tremelimumab × Clear all

NCT03075527 2026-01-08

A Phase 2 Study of Durvalumab in Combination With Tremelimumab in Malignant Pleural Mesothelioma

Phase 2 Terminated

19 enrolled 12 charts

Other solid neoplasmThoracic

Mesothelioma

NCT02592551 2022-09-29

MEDI4736 Or MEDI4736 + Tremelimumab In Surgically Resectable Malignant Pleural Mesothelioma

Phase 2 Completed

24 enrolled 22 charts

Other solid neoplasmThoracic

Mesothelioma